Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

19 Apr 2011 07:00

RNS Number : 1280F
Microgen PLC
19 April 2011
 



microgen

www.microgen.com

 

19 April 2011

 

INTERIM MANAGEMENT STATEMENT

 

Ahead of the Company's Annual General Meeting later today, Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 January 2011 to the date of this announcement. Microgen released its final results for the year ending 31 December 2010 on 24 February 2011.

 

The Group's financial results for the three months ended 31 March 2011 are in line with the Board's expectations. There have been no significant changes in the trading or financial position of Microgen and its balance sheet remains strong. Microgen had cash at 31 March 2011 of £27.5 million (31 December 2010: £25.4 million) and net funds of £25.8 million (31 December 2010: £23.6 million), prior to the proposed dividend payment in May of £1.7 million.

 

The Microgen Aptitude Solutions Division has made a good start to the year continuing to deliver strong growth with a number of new licence agreements and extensions. The Financial Systems Division continues to perform satisfactorily in a flat market environment, underpinned by the Division's high recurring revenue and the Group's annual software licencing model.

 

Reflecting the evolution of his role, the Board has now promoted David Sherriff to Chief Executive Officer. Also, the Board has appointed Peter Bertram, who is currently a non-executive director and chairman of the audit committee, as the senior independent non-executive director.

 

While it is still early in the year and the Board remains cautious and prudent, Microgen has started the year well and remains on track to meet the Board's expectations.

 

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSIPMATMBABBJB
Date   Source Headline
3rd Mar 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:01 amRNSBoard Transition
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:43 amRNSTotal Voting Rights
31st Jan 20255:39 pmRNSNotification of Major Holdings
30th Jan 20254:58 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 202510:41 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 202510:47 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202410:06 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.